Abstract

For many years innumerable claims have been made for blood tests capable of detecting the presence of clinically occult cancer, but none of the many ‘cancer tests’ has withstood detailed evaluation. However, some are available with potential use in screening for neoplasia, for making the initial diagnosis, for localisation of occult neoplasia and monitoring response to therapy, and for early detection of tumour recurrence. The whole field has recently been critically reviewed by Neville and Cooper [54]. Cancer testing can be divided into observations on (1) immunological phenomena associated with cancer, (2) substances produced in response to tumours, (3) tumour-derived products and (4) miscellaneous tests.

Keywords

Cortisol Pancreatitis Ferritin Osteogenic Sarcoma Pyrimidine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abelev, G. I.: α-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues. Transplant. Rev. 20, 3–37 (1974).PubMedGoogle Scholar
  2. 2.
    Adams, W. C., Davis, F., Nakatani, M.: Purine and pyrimidine excretion in normal and leukemic subjects. Amer. J. Med. 28, 726–734 (1960).PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson, G.: The incidence of paramalignant syndromes. In: Paramalignant Syndromes In Lung Cancer. London: William Heinemann, 1973, p. 4.Google Scholar
  4. 4.
    Azzopardi, J. G., Freeman, E., Poole, G.: Endocrine and metabolic disorders in bronchial carcinoma. Brit. Med. J. IV, 528–530 (1970).CrossRefGoogle Scholar
  5. 5.
    Azzopardi, J. G., Whittaker, R. S.: Bronchial carcinoma and hypercalcaemia. J. clin. Path. 22, 718–724 (1969).PubMedCrossRefGoogle Scholar
  6. 6.
    Bagshawe, K. D.: The clinical biology of the trophoblast and its tumours. In: Choriocarcinoma. London: Edward Arnold, 1969.Google Scholar
  7. 7.
    Bagshawe, K. D.: Tumour associated antigens. Brit. med. Bull. 30, 68–73 (1974).PubMedGoogle Scholar
  8. 8.
    Bagshawe, K. D., Rogers, G. T., Searle, F., Wilson, H.: Blood carcinoembryonic antigen, Regan isoenzyme, and human chorionic gonadotrophin in primary mediastinal carcinoma. Lancet (1973) I, 210–211.CrossRefGoogle Scholar
  9. 9.
    Baldwin, R. W., Embleton, M. J.: Assessment of cell-mediated immunity to human tumour associated antigens. Int. Rev. exp. Path. 17, 49–95 (1977).PubMedGoogle Scholar
  10. 10.
    Barralet, V., Mach, J-P.: Variations of the carcinoembryonic antigen level in the plasma of patients with gynecologic cancers during therapy. J. Amer. Obstet. Gynec. 121, 164–168 (1975).Google Scholar
  11. 11.
    Belliveau, R. E., Yamamoto, L. A., Wassell, A. R., Wiernik, P. H.: Regan isoenzyme in patients with haematopoietic tumors. Amer. J. Clin. Path. 62, 329–334 (1974).Google Scholar
  12. 12.
    Bloomfield, G. A., Holdaway, I. M., Corrin, B., Ratcliffe, J. G., Rees, G. M., Ellison, Rees, L. H.: Lung tumours and ACTH secretion. Clin. Endoc. 6, 95–104 (1977).CrossRefGoogle Scholar
  13. 13.
    Braunstein, G. D., McIntire, K. R., Waldmann, T. A.: Discordance of human chorionic gonadotrophin and alpha-fetoprotein in testicular teratocarcinomas. Cancer 31, 1065–1068 (1973a).PubMedCrossRefGoogle Scholar
  14. 14.
    Braunstein, G. D., Vaitukaitis, J. L., Carbone, P. P., Ross, G. T.: Ectopic production of human chorionic gonadotrophin by neoplasms. Ann. Int. Med. 78, 39–45 (1973b).PubMedGoogle Scholar
  15. 15.
    Buffe, D., Rimbaut, C., Lemerle, J., Schweisguth, P., Burtin, P.: Presence d’une ferroproteine d’origine tissulaire, L’α2H dans le sérum des enfants porteurs de tumeurs. Int. J. Cancer 5, 85–87 (1970).PubMedCrossRefGoogle Scholar
  16. 16.
    Cercek, I., Cercek, B., Franklin, C. I. V.: Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders. Brit. J. Cancer 29, 345–358 (1970).CrossRefGoogle Scholar
  17. 17.
    Cercek, B., Cerek, L.: Changes in the structuredness of cytoplasmic matrix, SCM, in human lymphocytes induced by PHA and cancer basic protein as measured in single cells. Brit. J. Cancer 33, 539–543 (1976).PubMedCrossRefGoogle Scholar
  18. 18.
    Charles, M. A., Claypool, R., Schaaf, M., Rosen, S. W., Weintraub, B. D.: Lung carcinoma associated with production of three placental proteins. Arch. Int. Med. 132, 427–431 (1973).CrossRefGoogle Scholar
  19. 19.
    Chu, T. M., Nemoto, T. J.: Evaluation of carcinoembryonic antigen in human mammary carcinoma. J. Nat. Cancer Inst. 51, 1119–1122 (1972).Google Scholar
  20. 20.
    Cochran, A. J., Grant, R. M., Spilg, W. G., Mackie, R. M., Ross, C. E., Hoyle, D. E., Russell, J. M.: Sensitization to tumour-associated antigens in human breast carcinoma. Int. J. Cancer 14, 19–25 (1974).PubMedCrossRefGoogle Scholar
  21. 21.
    Cooper, E. H.: The nature of cancer. Ann. clin. Biochem. 13, 467–470 (1976).PubMedGoogle Scholar
  22. 22.
    Churchill, W. H.: Nat. Cancer Inst. Monogr. 35, 237 (1972).Google Scholar
  23. 23.
    Denton, M. D., Glazier, H. S., Walle, T., Zellner, D. C., Smith, F. G.: Clinical application of new methods of polyamine analysis. In: Polyamines in Normal and Neoplastic Growth. Russell, D. H. (ed.). New York: Raven Press 1973, pp. 373–380.Google Scholar
  24. 24.
    Dickinson, J. P., Caspary, E. A., Field, E. J.: Common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Brit. J. Cancer 27, 99–105 (1973).PubMedCrossRefGoogle Scholar
  25. 25.
    Dlugajczyk, A., Eiler, J. J.: Studies on 5-ribosyluracil in man. Proc. Soc. exp. Biol. (N.Y.) 123, 453–457 (1966).Google Scholar
  26. 26.
    Eagan, R. T., Maurer, L. H., Forcier, R. J., Tulloh, M.: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment and survival. Cancer 33, 527–532 (1974).PubMedCrossRefGoogle Scholar
  27. 27.
    Field, E. J.: The immunological diagnosis of human malignant disease. Ann. clin. Biochem. 13, 495–502 (1976).PubMedGoogle Scholar
  28. 28.
    Field, E. J., Caspary, E. A.: Lymphocyte sensitisation: an in vitro test for cancer? Lancet (1970) II, 1337–1341.CrossRefGoogle Scholar
  29. 29.
    Field, E. J., Caspary, E. A.: Lymphocyte sensitisation in advanced malignant disease: a study of serum lymphocyte depressive factor. Brit. J. Cancer 26, 164–173 (1972).PubMedCrossRefGoogle Scholar
  30. 30.
    Fishman, W. H., Inglis, N. R., Green, S., Anstiss, C. L., Ghosh, N. K., Reif, A. E., Rustigian, R., Krant, M. J., Stolbach, L. L.: Immunology and biochemistry of regan isoenzyme of phosphatase in human cancer. Nature 219, 697–699 (1968).PubMedCrossRefGoogle Scholar
  31. 31.
    Gaspard, U., Hendrick, J. C., Reuter, A. M., Franchimont, P.: Dosage radioimmunologique de l’hormone chorionique sommatamammotrope humaine (HCS) par lés immunoadsorbant anticorps. Ann. Biol. Clin. (Paris). 31, 447–454 (1973).Google Scholar
  32. 32.
    Gau, G., Chard, T.: Pregnancy proteins in breast cancer. Lancet (1976) II, 627.CrossRefGoogle Scholar
  33. 33.
    Gewirtz, G., Yalow, R. S.: Ectopic ACTH production in carcinoma of the lung. J. clin. Invest. 53, 1022–1023 (1974).PubMedCrossRefGoogle Scholar
  34. 34.
    Gilby, E. D., Rees, L. H., Bondy, P. J.: Ectopic hormones as markers of response to therapy in cancer. In: Biological Characterization of Human Tumours. Amsterdam: Excerpta Medica, 1975, pp. 132–138.Google Scholar
  35. 35.
    Gold, P., Freedman, S. O.: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and adsorption techniques. J. exp. Med. 121, 439–462 (1965).PubMedCrossRefGoogle Scholar
  36. 36.
    Grosser, N., Thomson, D. M. P.: Cell-mediated anti-tumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res. 35, 2571–2579 (1975).PubMedGoogle Scholar
  37. 37.
    Guzzo, C. E., Pachas, W. N., Pinals, R. S., Krant, M. J.: Urinary hydroxyproline excretion in patients with cancer. Cancer 24, 382–387 (1969).PubMedCrossRefGoogle Scholar
  38. 38.
    Hellstrom, I., Hellstrom, K. E.: Colony inhibition studies on blocking and non-blocking effects of cellular immunity to Moloney sarcomas. Int. J. Cancer 5, 195–201 (1970).PubMedCrossRefGoogle Scholar
  39. 39.
    Hendrick, J. C., Franchimont, P.: Radioimmunoassay of casein in the serum of normal subjects and of patients with various malignancies. Europ. J. Cancer 10, 725–730 (1974).CrossRefGoogle Scholar
  40. 40.
    Heppner, G., Henry, E., Stolbach, L., Cummings, F.: Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. Cancer Res. 35, 1931–1937 (1975).PubMedGoogle Scholar
  41. 41.
    Heyderman, E., Neville, A. M.: Immunoperoxidase localisation of pregnancy protein. Lancet (1976) II, 744.CrossRefGoogle Scholar
  42. 42.
    Horne, C. H. W., Reid, I. N., Milne, G. D.: Prognostic significances of inappropriate production of pregnancy proteins by breast cancers. Lancet (1976) II, 279–282.CrossRefGoogle Scholar
  43. 43.
    Horne, C. H. W., Reid, I. N., Towler, C. M., Milne, G. D.: Production of pregnancy specific β 1 glycoprotein by non-trophoblastic tumours. Protides of Biological Fluids 24, 567–570 (1976).Google Scholar
  44. 44.
    Inglis, N. R., Kirley, S., Stolbach, L. L., Fishman, W. H.: Phenotypes of the Regan isoenzyme and identity between placental D-variant and the Nagao isoenzyme. Cancer Res. 33, 1657–1661 (1973).PubMedGoogle Scholar
  45. 45.
    Jacoby, B., Bagshawe, K. D.: A radioimmunoassay for placental-type alkaline phosphatase. Cancer Res. 32, 2413–2420 (1972).PubMedGoogle Scholar
  46. 46.
    Kato, Y., Ferguson, T. B., Bennett, D. E., Burford, T. H.: Oat cell carcinoma of the lung. A review of 138 cases. Cancer 23, 681–686 (1969).CrossRefGoogle Scholar
  47. 47.
    Kohn, J., Orr, A. H., McElwain, T. J., Bentall, M., Peckham, M. J.: Serum alpha fetoprotein in patients with testicular tumours. Lancet (1976) II, 433–436.CrossRefGoogle Scholar
  48. 48.
    Lajtha, L. G.: Fluorescence probe and biochemical characterization of leukaemic cells. Blood Cells 1, 63–65 (1975).Google Scholar
  49. 49.
    Laurence, D. J. R., Neville, A. M.: Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Brit. J. Cancer 26, 335–355 (1972).PubMedCrossRefGoogle Scholar
  50. 50.
    Leek, A. E., Ruoss, C. F., Kitau, M. J., Chard, T.: Raised alpha fetoprotein in maternal serum with anencephalic pregnancy. Lancet (1973) II, 385.CrossRefGoogle Scholar
  51. 51.
    Leighton, P. C., Gordon, Y. B., Kitau, M. J., Leek, A. E., Chard, T.: Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Lancet (1975) II, 1012–1019.CrossRefGoogle Scholar
  52. 52.
    Locks, M. O.: Incidence of hypercalcaemia in patients with proved carcinoma of the lung. Lancet (1962) II, 165–167.Google Scholar
  53. 53.
    Muggia, F. M., Rosen, S. W., Weintraub, B. D., Hansen, H. H.: Ectopic placental proteins in non-trophoblastic tumors. Cancer 36, 1327–1337 (1975).PubMedCrossRefGoogle Scholar
  54. 54.
    Neville, A. M., Cooper, E. H.: Biochemical monitoring of cancer. Ann. clin. Biochem. 13, 283–305 (1976).PubMedGoogle Scholar
  55. 55.
    Newlands, E. S., Dent, S., Kardana, A., Searle, F., Bagshawe, K. D.: Serum α1-feto protein and HCG in patients with testicular tumours. Lancet (1976) II, 744–745.CrossRefGoogle Scholar
  56. 56.
    Owen, J. J. T.: Cellular Immunity. Ann. Clin. Biochem. 13, 485–487 (1976).PubMedGoogle Scholar
  57. 57.
    Powles, T. J., Leese, C. L. Bondy, P. K.: Hydroxyproline excretion in patients with breast cancer and response to treatment. Brit. Med. J. 2, 164–166 (1975).PubMedCrossRefGoogle Scholar
  58. 58.
    Purves, L. R., Branch, W. R., Geddes, E. W., Manso, E., Portugal, M.: Serum alpha-fetoprotein VII. The range of apparent serum values in normal people, pregnant women and primary liver cancer high risk populations. Cancer 31, 578–587 (1973).PubMedCrossRefGoogle Scholar
  59. 59.
    Radom, S., Zulawaski, M., Golebiowska, D.: Urinary hydroxyproline, serum alkaline phosphatase calcium and phosphorus in patients with bone neoplasms. Polish Med. J. 11, 810–814 (1972).Google Scholar
  60. 60.
    Rees, L. H.: The biosynthesis of hormones by non-endocrine tumours—a review. J. Endocr. 67, 143–175 (1975).PubMedCrossRefGoogle Scholar
  61. 61.
    Rees, L. H.: Concepts in ectopic hormone production. Clin. Endocr. 5, (Suppl.), 363s–372s (1976).CrossRefGoogle Scholar
  62. 62.
    Rees, L. H., Bloomfield, G. A., Rees, G. M., Corrin, B., Franks, L. M., Ratcliffe, J. G.: Multiple hormones in a bronchial tumor. J. clin. Endocr. Metab. 38, 1090–1097 (1974).PubMedCrossRefGoogle Scholar
  63. 63.
    Rees, L. H., Landon, J.: Biochemical abnormalities of some human neoplasms. In: Scientific Foundations of Oncology. Symington, T., Carter, R. L. (eds.). London: William Heinemann, 1976, pp. 107–116.Google Scholar
  64. 64.
    Rosen, S. W., Weintraub, B. D.: Ectopic production of the isolated alpha subunit of the glycoprotein hormones. New Eng. J. Med. 290, 1441–1447 (1974).PubMedCrossRefGoogle Scholar
  65. 65.
    Ruoslahti, E., Pihko, H., Seppälä, M.: α-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease. Transplant. Rev. 20, 38–60 (1974).PubMedGoogle Scholar
  66. 66.
    Silver, H. K. B., Deneault, J. Gold, P., Thompson, W. G., Shuster, J., Freedman, S. O.: The detection of alpha 1-fetoprotein in patients with viral hepatitis. Cancer Res. 34, 244–247 (1974).PubMedGoogle Scholar
  67. 67.
    Snyder, S. H., Russel, D. H.: Polyamine synthesis in rapidly growing tissues. Fed. Proc. 29, 1575–1582 (1970).PubMedGoogle Scholar
  68. 68.
    Solberg, H. E.: Discriminant analysis in clinical chemistry. Scand. J. Clin. Lab. Invest. 35, 705–712 (1975).PubMedCrossRefGoogle Scholar
  69. 69.
    Stevens, L.: The biochemical role of naturally occurring polyamines in nucleic acid synthesis. Biol. Rev. 45, 1–27 (1970).PubMedCrossRefGoogle Scholar
  70. 70.
    Stimson, W. H.: Correlation of the blood-level of a pregnancy-associated macroglobulin with the clinical course in cancer patients. Lancet (1975) I, 777–779.CrossRefGoogle Scholar
  71. 71.
    Stimson, W. H., Sinclair, J. M.: An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates. Febs. Letts. 47, 190–192 (1974).CrossRefGoogle Scholar
  72. 72.
    Takasugi, M., Mickey, M. R., Teresaki, P. I.: Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 33, 2898–2902 (1973).PubMedGoogle Scholar
  73. 73.
    Tormey, D. C., Waalkes, T. P., Ahmann, D., Gehrke, C. W., Zumwatt, R. W., Snyder, J., Hansen, H.: Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines and three minor nucleosides. Cancer 35, 1095–1100 (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1977

Authors and Affiliations

  • L. H. Rees

There are no affiliations available

Personalised recommendations